Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Laforce

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Clinical Nuclear Medicine|July 27, 2019
The Use of Random Forests to Classify Amyloid Brain PETKatherine Zukotynski, Vincent Gaudet, Phillip H Kuo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scalesDavid F Tang-Wai, Eric E Smith, Marie-Andrée Bruneau, et al.
Neurobiology of Aging|November 25, 2017
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI studyDavid M Cash, Martina Bocchetta, David L Thomas, et al.
Clinical Nuclear Medicine|May 6, 2020
The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA ScoreKatherine Zukotynski, Vincent Gaudet, Phillip H Kuo, et al.
Neuroimage|December 12, 2018
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohortClaire Cury, Stanley Durrleman, David M Cash, et al.
Molecular Neurodegeneration|November 28, 2021
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI studySofia Bergström, Linn Öijerstedt, Julia Remnestål, et al.
Neuroimage. Clinical|May 23, 2017
White matter hyperintensities are seen only in <i>GRN</i> mutation carriers in the GENFI cohortCarole H Sudre, Martina Bocchetta, David Cash, et al.
Annals of Clinical and Translational Neurology|April 26, 2019
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomicsEmma L van der Ende, Lieke H Meeter, Christoph Stingl, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Clinical Nuclear Medicine|July 27, 2019
The Use of Random Forests to Classify Amyloid Brain PETKatherine Zukotynski, Vincent Gaudet, Phillip H Kuo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scalesDavid F Tang-Wai, Eric E Smith, Marie-Andrée Bruneau, et al.
Neurobiology of Aging|November 25, 2017
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI studyDavid M Cash, Martina Bocchetta, David L Thomas, et al.
Clinical Nuclear Medicine|May 6, 2020
The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA ScoreKatherine Zukotynski, Vincent Gaudet, Phillip H Kuo, et al.
Neuroimage|December 12, 2018
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohortClaire Cury, Stanley Durrleman, David M Cash, et al.
Molecular Neurodegeneration|November 28, 2021
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI studySofia Bergström, Linn Öijerstedt, Julia Remnestål, et al.
Neuroimage. Clinical|May 23, 2017
White matter hyperintensities are seen only in <i>GRN</i> mutation carriers in the GENFI cohortCarole H Sudre, Martina Bocchetta, David Cash, et al.
Annals of Clinical and Translational Neurology|April 26, 2019
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomicsEmma L van der Ende, Lieke H Meeter, Christoph Stingl, et al.
Neurology|October 4, 2019
Ventricular volume expansion in presymptomatic genetic frontotemporal dementiaTamara P Tavares, Derek G V Mitchell, Kristy Coleman, et al.
Pageof 22